NCT00812045 - Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Study Completion Date

August 31, 2010

Conditions

Cystic Fibrosis

Interventions

DRUG

AZD1236

Oral tablet, 75 mg twice daily during 4 weeks

DRUG

Placebo

Trial Locations (10)

Research Site, Montreal

Research Site, Ottawa

Research Site, Vancouver

Research Site, Amsterdam

Research Site, Groningen

Research Site, Utrecht

Research Site, Gdansk

Research Site, Poznan

Research Site, Barcelona

Research Site, Madrid